Skip to main content

Table 5 Plasma clinical parameters in rats following 14 days treatment with FBA

From: Evaluation of the hepato-renal functions and antimicrobial activity of fatty amido benzoic acid synthesised from Citrullus colocynthis seed oil

Parameters

A

B

C

D

AST, U/l

104.8 ± 6.1

111.9 ± 12.8

104.8 ± 8.1

200.6 ± 18.7**

ALT, U/I

43.0 ± 6.1

72.1 ± 3.4*

71.2 ± 10.3*

84.7 ± 3.4**

Total Bilirubin

14.6 ± 1.4

14.6 ± 1.2

14.8 ± 1.1

17.5 ± 1.1

Albumin, g/dl

3.2 ± 0.1

1.6 ± 0.1**

3.1 ± 0.1

3.2 ± 0.1

Creatinine, µmol/l

88.4 ± 8.7

100.8 ± 8.8

115.4 ± 6.4

118.1 ± 6.9*

Urea, mmol/l

0.7 ± 0.02

1.2 ± 0.01**

1.1 ± 0.03**

1.3 ± 0.02**

Potassium, mEq/l

1.9 ± 0.2

2.5 ± 0.2*

2.8 ± 0.01**

2. 7 ± 0.1**

Sodium, mEq/l

140.7 ± 2.8

138.7 ± 3.4

140.1 ± 3.1

133.0 ± 0.1

  1. Values are expressed as mean ± SE for five rats in each group. A, Control; B, FBA (10 mg kg−1); C, FBA (50 mg kg−1); D, FBA (100 mg kg−1); *significantly different from control (p < 0.05). **Significantly different from control (p < 0.01)